1. Home
  2. SLNO vs CNMD Comparison

SLNO vs CNMD Comparison

Compare SLNO & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • CNMD
  • Stock Information
  • Founded
  • SLNO 1999
  • CNMD 1970
  • Country
  • SLNO United States
  • CNMD United States
  • Employees
  • SLNO N/A
  • CNMD N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • SLNO Health Care
  • CNMD Health Care
  • Exchange
  • SLNO Nasdaq
  • CNMD Nasdaq
  • Market Cap
  • SLNO 1.9B
  • CNMD 2.2B
  • IPO Year
  • SLNO 2014
  • CNMD 1987
  • Fundamental
  • Price
  • SLNO $54.63
  • CNMD $71.73
  • Analyst Decision
  • SLNO Strong Buy
  • CNMD Buy
  • Analyst Count
  • SLNO 7
  • CNMD 6
  • Target Price
  • SLNO $69.86
  • CNMD $82.83
  • AVG Volume (30 Days)
  • SLNO 504.7K
  • CNMD 454.9K
  • Earning Date
  • SLNO 11-06-2024
  • CNMD 10-30-2024
  • Dividend Yield
  • SLNO N/A
  • CNMD 1.12%
  • EPS Growth
  • SLNO N/A
  • CNMD 127.53
  • EPS
  • SLNO N/A
  • CNMD 4.22
  • Revenue
  • SLNO N/A
  • CNMD $1,288,116,000.00
  • Revenue This Year
  • SLNO N/A
  • CNMD $6.69
  • Revenue Next Year
  • SLNO N/A
  • CNMD $7.45
  • P/E Ratio
  • SLNO N/A
  • CNMD $16.87
  • Revenue Growth
  • SLNO N/A
  • CNMD 10.23
  • 52 Week Low
  • SLNO $26.38
  • CNMD $61.05
  • 52 Week High
  • SLNO $59.75
  • CNMD $117.27
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 51.30
  • CNMD 53.59
  • Support Level
  • SLNO $50.69
  • CNMD $69.33
  • Resistance Level
  • SLNO $59.75
  • CNMD $73.60
  • Average True Range (ATR)
  • SLNO 2.47
  • CNMD 3.03
  • MACD
  • SLNO -0.48
  • CNMD -0.18
  • Stochastic Oscillator
  • SLNO 43.47
  • CNMD 33.69

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.

About CNMD CONMED Corporation

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.

Share on Social Networks: